Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3748/wjg.v22.i24.5459

http://scihub22266oqcxt.onion/10.3748/wjg.v22.i24.5459
suck pdf from google scholar
C4917606!4917606 !27350724
unlimited free pdf from europmc27350724
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27350724 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid27350724
      World+J+Gastroenterol 2016 ; 22 (24 ): 5459-66
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Natural regression of fibrosis in chronic hepatitis B #MMPMID27350724
  • Ohkoshi S ; Hirono H ; Watanabe K ; Hasegawa K ; Kamimura K ; Yano M
  • World J Gastroenterol 2016[Jun]; 22 (24 ): 5459-66 PMID27350724 show ga
  • The fibrosis of liver cirrhosis was considered to be irreversible before the anti-viral drugs showed that it is reversible when they lead to continuous suppression of viral replication and inflammation. However, several reports previously showed that fibrosis of type B liver cirrhosis was almost completely absorbed after the natural remission of chronic inflammation. This phenomenon might not be limited to exceptional patients, but rather occur commonly, considering the dynamic clinical features of chronic hepatitis B (CHB), where inactive carrier stage normally follows aggravation of hepatitis and progression of fibrosis at the time of HBeAg seroconversion. Thus, fibrosis levels of CHB as a hepatocellular carcinoma (HCC)-surveillance marker, particularly those of the inactive stage, could be underestimated, because some of them might have been (pre)cirrhotic in the past and recovered with the natural regression of fibrosis. We argue that cirrhosis-induced HCC mechanisms, rather than direct action of viral genome, may be more common than generally considered in CHB patients. This may have some impact on reconsidering the surveillance rationale for HCC in CHB, from where advanced HCCs tended to be missed. In addition, a molecular marker to assess the cancer-prone characteristics of the liver will definitely be needed to resolve the issue.
  • |Carcinoma, Hepatocellular/*diagnosis/etiology/immunology [MESH]
  • |Disease Progression [MESH]
  • |Early Detection of Cancer [MESH]
  • |Hepatitis B e Antigens/immunology [MESH]
  • |Hepatitis B, Chronic/complications/immunology/*physiopathology [MESH]
  • |Humans [MESH]
  • |Inflammation [MESH]
  • |Liver Cirrhosis/etiology/immunology/*physiopathology [MESH]
  • |Liver Neoplasms/*diagnosis/etiology/immunology [MESH]
  • |Remission, Spontaneous [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box